epiglucan and Swine-Diseases

A non-blinded randomized clinical trial was conducted to assess the immunomodulatory potential of β-glucan (BG) in piglet diarrhoea associated with type A rotavirus infection. A total of 12 rotavirus-infected diarrheic piglets were randomly divided into two groups: wherein six rotavirus-infected piglets were treated with supportive treatment (ST) and other six rotavirus-infected piglets were treated with BG along with ST (ST-BG). Simultaneously, six healthy piglets were also included in the study which served as control. In rotavirus-infected piglets, marked increase of Intestinal Fatty Acid Binding Protein-2 (I-FABP2), nitric oxide (NOx), Interferon-γ (IFN-γ) concentrations and decrease of immunoglobulin G (IgG) were noticed compared to healthy piglets. The faecal consistency and dehydration scores were significantly higher in rotavirus-infected piglets than healthy piglets. The ST-BG treatment progressively reduced the I-FABP2 and increased the IgG concentrations over the time in rotavirus-infected piglets compared to piglets received only ST. A pronounced enhancement of NOx and IFN-γ concentrations was observed initially on day 3 and thereafter the values reduced on day 5 in ST-BG treated piglets in comparison to piglets which received only ST. Additionally, ST-BG treatment significantly reduced faecal consistency and dehydration scores on day 3 compared to ST in rotavirus-infected piglets. These findings point that BG represents a potential additional therapeutic option to improve the health condition and reduce the piglet mortality from rotavirus associated diarrhoea where porcine rotavirus vaccine is not available.

Topics: Animals; beta-Glucans; Enteritis; Fatty Acid-Binding Proteins; Female; Immunity, Innate; Immunologic Factors; Intestines; Male; Nitric Oxide; Rotavirus Infections; Swine; Swine Diseases

The effect of orally administered beta-glucans in protecting pigs against an ETEC infection after weaning was analysed in this study. Three beta-glucans that differed in origin (Saccharomyces cerevisiae (MCG (Macrogard) and G2) or Sclerotium rolfsii (G3)) and/or extraction procedure were tested. Pigs fed for 2 weeks after weaning with these glucans were less susceptible to an F4+ ETEC infection in comparison with the control group. This was evidenced by a reduction in the faecal excretion of F4+ Escherichia coli as well as a reduced F4-specific serum antibody response. This decrease in faecal excretion was statistically significant for pigs fed with the MCG glucan in a first experiment and with the G3 glucan in a second experiment; diarrhoea was milder in the glucan-supplemented groups and was significantly reduced in the MCG-supplemented group. Furthermore, a lower amount of F4-specific IgM antibody-secreting cells (ASC) was found in the lymphoid tissues of pigs fed with G2 or G3 glucans in comparison with the control pig, as well as lower F4-specific IgA ASC in G3-fed pigs in comparison with the control pig. This study showed that beta-glucans can protect against an ETEC infection. Both MCG from S. cerevisiae and G3 from S. rolfsii, resulted in significant effects. To our knowledge, this is the first in vivo study, in which the use of beta-glucans as feed ingredient for just-weaned piglets was tested for their protective effects against ETEC infection.

Topics: Animal Feed; Animals; beta-Glucans; Diarrhea; Diet; Dietary Supplements; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Immunoglobulins; Swine; Swine Diseases; Weaning

Alternatives to antibiotics to improve animal performance, limit the negative impact of infectious disease, and/or reduce colonization with foodborne pathogens is a major focus of animal agricultural research. β-glucans, a generally-recognized-as-safe (GRAS) product derived from various sources, are used in swine and can serve as both a prebiotic and/or stimulant of the immune system given the expression of β-glucan receptors on immune cells. When supplied in the diet of nursery pigs, it is unclear how dietary additives, particularly those known to modulate immune status, impact immunogenicity and efficacy of mucosal-delivered vaccines. Salmonellosis is one of the most common bacterial foodborne infections in the United States, and consumption of contaminated pork is a major source of human infection. Reduction of foodborne Salmonella in pigs via vaccination is one strategy to reduce contamination risk and subsequently reduce human disease. We examined the ability of dietary β-glucan to modulate fecal microbial diversity, and immunogenicity and efficacy of a mucosally-delivered, live-attenuated Salmonella vaccine during the nursery period. While dietaryβ-glucan did modulate fecal alpha diversity, it did not alter the induction of peripheral Salmonella-specific IFN-γ secreting Tcells or Salmonella-specific IgA in oral fluids. In addition, vaccination reduced Salmonella enterica serovar Typhimurium fecal shedding and tissue colonization. Overall, addition of β-glucan to the nursery diet of pigs impacted the microbiota but did not alter mucosal vaccine immunogenicity and efficacy.

Topics: Animals; beta-Glucans; Diet; Humans; Immunogenicity, Vaccine; Salmonella Infections, Animal; Salmonella typhimurium; Salmonella Vaccines; Swine; Swine Diseases; Vaccines, Attenuated

To explore the protective effect of dietary β-glucan (BGL) supplementation on intestinal epithelium exposure to enterotoxigenic Escherichia coli (ETEC), thirty-two weaned pigs were assigned to four groups. Pigs were fed with a basal diet or basal diet containing 500 mg/kg BGL, and were orally infused with ETEC or culture medium. Results showed BGL supplementation had no influence on growth performance in weaned pigs. However, BGL supplementation increased the absorption of D-xylose, and significantly decreased the serum concentrations of D-lactate and diamine oxidase (DAO) in the ETEC-challenged pigs (p < 0.05). Interestingly, BGL significantly increased the abundance of the zonula occludens-1-(ZO-1) in the jejunal epithelium upon ETEC challenge (p < 0.05). BGL supplementation also increased the number of S-phase cells and the number of sIgA-positive cells, but significantly decreased the number of total apoptotic cells in the jejunal epithelium upon ETEC challenge (p < 0.05). Moreover, BGL significantly increased the duodenal catalase (CAT) activity and the ileal total superoxide dismutase (T-SOD) activity in the ETEC-challenged pigs (p < 0.05). Importantly, BGL significantly decreased the expression levels of critical inflammation related proteins such as the tumor necrosis factor-α (TNF-α), interlukin-6 (IL-6), myeloid differentiation factor 88 (MyD88), and nuclear factor-κB (NF-κB) in the jejunal and ileal mucosa upon ETEC challenge (p < 0.05). BGL also elevated the propanoic acid content and the abundance of Lactobacillus and Bacillus in the colon upon ETEC challenge (p < 0.05). These results suggested BGL could alleviate the ETEC-induced intestinal epithelium injury, which may be associated with suppressed inflammation and improved intestinal immunity and antioxidant capacity, as well as the improved intestinal macrobiotic.

Topics: Agrobacterium; Amine Oxidase (Copper-Containing); Animals; Antioxidants; beta-Glucans; Catalase; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Immunoglobulin A, Secretory; Inflammation; Interleukin-6; Intestinal Mucosa; Lactates; Myeloid Differentiation Factor 88; NF-kappa B; Propionates; Superoxide Dismutase; Swine; Swine Diseases; Tumor Necrosis Factor-alpha; Xylose

Actinobacillus pleuropneumoniae is the etiological agent of porcine pleuropneumonia, an economically important disease of pigs. The hfq gene in A. pleuropneumoniae, encoding the RNA chaperone and posttranscriptional regulator Hfq, is upregulated during infection of porcine lungs. To investigate the role of this in vivo-induced gene in A. pleuropneumoniae, an hfq mutant strain was constructed. The hfq mutant was defective in biofilm formation on abiotic surfaces. The level of pgaC transcript, encoding the biosynthesis of poly-β-1,6-N-acetylglucosamine (PNAG), a major biofilm matrix component, was lower and PNAG content was 10-fold lower in the hfq mutant than in the wild-type strain. When outer membrane proteins were examined, cysteine synthase, implicated in resistance to oxidative stress and tellurite, was not found at detectable levels in the absence of Hfq. The hfq mutant displayed enhanced sensitivity to superoxide generated by methyl viologen and tellurite. These phenotypes were readily reversed by complementation with the hfq gene expressed from its native promoter. The role of Hfq in the fitness of A. pleuropneumoniae was assessed in a natural host infection model. The hfq mutant failed to colonize porcine lungs and was outcompeted by the wild-type strain (median competitive index of 2 × 10(-5)). Our data demonstrate that the in vivo-induced gene hfq is involved in the regulation of PNAG-dependent biofilm formation, resistance to superoxide stress, and the fitness and virulence of A. pleuropneumoniae in pigs and begin to elucidate the role of an in vivo-induced gene in the pathogenesis of pleuropneumonia.

Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Amino Acid Sequence; Animals; Base Sequence; beta-Glucans; Biofilms; Electrophoresis, Polyacrylamide Gel; Host Factor 1 Protein; Molecular Sequence Data; Pleuropneumonia; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Swine; Swine Diseases; Virulence

We are developing a serotyping system for Actinobacillus suis based on its capsule (K) and lipopolysaccharide O-chain (O) structures. Previously, we have shown that less virulent strains of this swine pathogen express a (1→6)-β-D-glucan as both K- and O-chain polysaccharides and were serologically classified as K:1/O:1. Here, we show that representative A. suis strains with a high (H91-0380; serotype K:2/O:2) and intermediate (C84; serotype K:2/O:1) degree of virulence possess a capsule polysaccharide (K:2) composed of an O-acetylated diglycosyl phosphate repeat decorated with fructose: [→4)-3-O-Ac-β-D-GlcpNAc-(1→3)-[β-D-Fruf-(2→2)]-α-D-Galp-(1→PO(4)(-)→]. In addition, the serotype O:2 lipopolysaccharide was shown to express a sialylated O-chain [→3)-β-D-Galp-(1→4)-[Neu5Ac-(2→3)-α-D-Galp-(1→6)]-β-D-Glcp-(1→6)-β-D-GlcpNAc-(1→]. As (1→6)-β-D-glucan is ubiquitous in the environment, low levels of antibodies in the animals are predicted to prevent disease by K:1/O:1 strains. The greater potential associated with K:2/O:2 and K:2/O:1 strains is most likely due to the absence of (1→6)-β-D-glucan as the K antigen and, in the case of K:2/O:2, the presence of sialic acid in the lipopolysaccharide, a nonulosonic acid known to promote evasion of host recognition.

Topics: Acetylation; Actinobacillus Infections; Actinobacillus suis; Animals; Antigens, Bacterial; Antigens, Surface; Bacterial Capsules; beta-Glucans; Carbohydrate Sequence; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Molecular Sequence Data; N-Acetylneuraminic Acid; O Antigens; Polysaccharides, Bacterial; Serotyping; Sus scrofa; Swine; Swine Diseases; Virulence Factors

beta-Glucans are conserved glucose polymers found in the cell walls of plants, fungi, yeasts and bacteria. They have the capacity to activate innate immunity, thereby enhancing defence barriers. Besides differences in type of linkage and branching, beta-glucans can vary in solubility, molecular mass, tertiary structure, polymer charge and solution conformation. All these characteristics may influence their immunomodulating effects. In this study, the effect of seven beta-glucans that differed in origin (fungi, yeast, seaweed, bacteria or algae) and structure (linear or branched; soluble, gel or particulate) were tested on peripheral blood mononuclear cells (PBMC) and neutrophils of the pig. We looked at lymphocyte proliferation, reactive oxygen species (ROS), production by neutrophils and monocytes and cytokine production. The soluble beta-glucans Laminarin and Sleroglucan did not activate ROS-production of monocytes and neutrophils while the particulate beta-glucans (beta-glucan from algae (Euglena gracilis)) and glucan preparations from baker's yeast (Macrogard, Saccharomyces cerevisiae and Zymosan) had a stimulating effect. The highest stimulation of lymphocyte proliferation occurred by Curdlan (bacteria), Zymosan and the beta-glucan of E. gracilis, especially at high concentrations (200 microg/ml and 800 microg/ml). TNF-alpha was particularly stimulated by Macrogard and S. cerevisiae, while all beta-glucans (except Laminarin) induced IL-1beta. Furthermore, it was interesting that all beta-glucans and in particular Curdlan, gave rise to IL-10 secretion, whereas any beta-glucan induced the release of IL-8, IL-4, IL-12, IL-6 or IFN-gamma.

Topics: Adjuvants, Immunologic; Animals; beta-Glucans; Cell Proliferation; Cytokines; Immunity, Innate; In Vitro Techniques; Infection Control; Infections; Leukocytes; Lymphocytes; Molecular Structure; Monocytes; Neutrophils; Reactive Oxygen Species; Swine; Swine Diseases

The present study tested the action of Beta-glucan in swine experimentally infected with tachyzoites of Toxoplasma gondii. The experiment design used 8 mixed breed pigs (21 days) divided into three groups: G1 (Beta-glucan treated and infected, n = 3), G2 (untreated and infected, n = 3), and G3 (untreated uninfected, n = 2). The G1 animals were treated with 1g of Beta-glucan by intramuscularly route at days 0, 14, and 28 before experimental infection, while the other groups (G2 and G3) received only saline. The G1 and G2 were infected with viable tachyzoites (107) of the RH strain at day 35 of experiment. The parasitemy was determined by mouse bioassay and PCR from whole blood of each swine, obtained at days 3, 7, 14, 21, 31, 39, 47 e 69 post infections. The antibody levels of serum, aqueous and vitreous humor were measured by indirect immunofluorescence assay (IFA); a title >/= 64 was considered as positive. There were differences in the hematocrit, hemoglobin, plasmatic proteins, and eosinophils values between groups (P< 0.05). The swine of G1 and G2 serum converted 7 days post infection, and the highest title observed was 1024 in two pigs. Samples of aqueous and vitreous humor did not show antibodies against T. gondii. Parasite was detected of whole blood on days 3, 14, 31, 39, and 47 in two animals from G1, and three animals from G2. There were no differences between PCR and mouse bioassay. Animals from G3 remained without parasitemy by both PCR and bioassay throughout the experiment. The use of Beta-glucan, as was used here, was not protective for pigs against T. gondii tachyzoites acute infection. Additionally, the lineage of RH strain showed nonpersistent for pigs (muscles and retina) 69 days after infection.

Topics: Animals; beta-Glucans; Swine; Swine Diseases; Toxoplasmosis, Animal